The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
IFITM5 mutations and osteogenesis imperfecta
Abstract
Interferon-induced transmembrane protein 5 (IFITM5) is an osteoblast-specific membrane protein that has been shown to be a positive regulatory factor for mineralization in vitro. However, Ifitm5 knockout mice do not exhibit serious bone abnormalities, and thus the function of IFITM5 in vivo remains unclear. Recently, a single point mutation (c.-14C>T) in the 5' untranslated region of IFITM5 was identified in patients with osteogenesis imperfecta type V (OI-V). Furthermore, a single point mutation (c.119C>T) in the coding region of IFITM5 was identified in OI patients with more severe symptoms than patients with OI-V. Although IFITM5 is not directly involved in the formation of bone in vivo, the reason why IFITM5 mutations cause OI remains a major mystery. In this review, the current state of knowledge of OI pathological mechanisms due to IFITM5 mutations will be reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IFITM5 (Interferon-Induced Transmembrane Protein 5) encodes an osteoblast-specific membrane protein involved in bone mineralization 51 .”
From Sex-specific gene expression signatures of calcific aortic valve stenosis in a large collection of human tissues (2026) · cites this paper as [51]
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H.-J., Benedict, W., & Bouck, N. P. (1999) · Science · doi:10.1126/science.285.5425.245 · Cited by 1,505
Brass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Rauch, F., & Glorieux, F. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16051-0 · Cited by 1,167
An Acylation Cycle Regulates Localization and Activity of Palmitoylated Ras Isoforms
Rocks, O., Peyker, A., Kahms, M., Verveer, P. J., Koerner, C., Lumbierres, M., Kuhlmann, J., Waldmann, H., Wittinghofer, A., & Bastiaens, P. I. H. (2005) · Science · doi:10.1126/science.1105654 · Cited by 838
IFITM3 restricts the morbidity and mortality associated with influenza
The GenISIS Investigators, Everitt, A. R., The MOSAIC Investigators, Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., et al. (2012) · Nature · doi:10.1038/nature10921 · Cited by 782
Marini, J. C., Forlino, A., Cabral, W. A., Barnes, A. M., San Antonio, J. D., Milgrom, S., Hyland, J. C., Körkkö, J., Prockop, D. J., De Paepe, A., et al. (2007) · Human Mutation · doi:10.1002/humu.20429 · Cited by 764
Palmitoylation of Intracellular Signaling Proteins: Regulation and Function
Smotrys, J. E., & Linder, M. E. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073954 · Cited by 610
Huang, I.-C., Bailey, C. C., Weyer, J. L., Radoshitzky, S. R., Becker, M. M., Chiang, J. J., Brass, A. L., Ahmed, A. A., Chi, X., Dong, L., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001258 · Cited by 603
CRTAP Is Required for Prolyl 3- Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta
Morello, R., Bertin, T. K., Chen, Y., Hicks, J., Tonachini, L., Monticone, M., Castagnola, P., Rauch, F., Glorieux, F. H., Vranka, J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.08.039 · Cited by 531
Research works printed but not linked: 2
- Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Balwi MA, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH (2010) Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 86:389–398 · DOI · Paper page
- Campeau PM, Lee BH (2013) Phenotyic variability of osteogenesis imperfect type V caused by an IFITM5 mutation. J Bone Miner Res 28:1523–1530 · DOI
Cited by
Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types
Jovanovic, M., Guterman-Ram, G., & Marini, J. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab017 · Cited by 167
“The S40L BRIL mutation occurs near the palmitoylation sites at S50 and S51 (64) (Figure 3).”
BackgroundCollagen transport and related pathways in Osteogenesis Imperfecta
Claeys, L., Storoni, S., Eekhoff, E. M. W., Elting, M. W., Wisse, L. E., Pals, G., Bravenboer, N., Maugeri, A., & Micha, D. (2021) · Human Genetics · doi:10.1007/s00439-021-02302-2 · Cited by 131
“Mutations in these genes are mostly autosomal recessive; an exception to this are mutations in IFITM5 (autosomal dominant), PLS3 and MBTPS2 (recessive X-linked) (Hanagata 2016).”
BackgroundInfluentialPharmacological and biological therapeutic strategies for osteogenesis imperfecta
Marom, R., Lee, Y., Grafe, I., & Lee, B. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31532 · Cited by 72
“This mutation introduces a new start codon adding 5 amino acid residues to the IFITM5 protein, and is thought to have a neomorphic effect through unknown mechanisms [Lietman et al., 2015; Hanagata, 2016].”
MECHANISMS IN ENDOCRINOLOGY: Genetics of human bone formation
Boudin, E., & Hul, W. V. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0990 · Cited by 45
Tüysüz, B., Elkanova, L., Alkaya, D. U., Güleç, Ç., Toksoy, G., Güneş, N., Yazan, H., Bayhan, A. I., Yıldırım, T., Yeşil, G., et al. (2021) · Bone · doi:10.1016/j.bone.2021.116293 · Cited by 36
Metadata
- Authors
- Hanagata, N.
- Affiliations
- Hokkaido University (JP)
- Corresponding author
- Hanagata, Nobutaka
- ORCID
- Hanagata, Nobutaka
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2015-06-02
- Volume
- 34
- Issue
- 2
- Pages
- 123-131
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W656739112
- Cited by
- 38
- References
- 79
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 1
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- IFITM5, osteogenesis imperfecta type V, osteogenesis imperfecta, genetic mutations, 5' untranslated region, osteoblasts, bone mineralization, interferon-induced transmembrane proteins, pathophysiological mechanisms
- MeSH terms
- Animals, Humans, Membrane Proteins, Mutation, Osteogenesis Imperfecta, Phenotype, Open Reading Frames
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IFITM5 mutations and osteogenesis imperfecta. https://app.cochat.ai/papers/10.1007/s00774-015-0667-1
- The paper
- Hanagata, N. (2016). IFITM5 mutations and osteogenesis imperfecta. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-015-0667-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.